NVS - Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration | Benzinga
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process.
Last year, about 9 million Medicare enrollees spent $3.4 billion out of pocket on the selected drugs from companies, including Johnson & Johnson (NYSE: JNJ), Merck & Co Inc (NYSE: MRK), Bristol Myers Squibb Co (NYSE: BMY), and AstraZeneca Plc (NASDAQ: